IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis

Laboratory Investigation

Volumn 89, Issue 10, 2009, Pages 1182-1186

  Lovisa, Federica ^a   Mussolin, Lara ^a   Corral, Lilia ^b   Pillon, Marta ^a   Cazzaniga, Giovanni ^b   Biondi, Andrea ^b   Rosolen, Angelo ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

B cell acute lymphoblastic leukemia; Burkitt's lymphoma; Child; Clonality; Immunoglobulin rearrangement; Minimal residual disease

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BURKITT LYMPHOMA; CHILD; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SENSITIVITY ANALYSIS;

BURKITT LYMPHOMA; CHILD; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; LEUKEMIA, B-CELL; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION;

EID: 70349546388     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.81     Document Type: Article

References (23)

1. Magrath IT, Ziegler JL. Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia. Leuk Res 1980;4:33-59.
2. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-458.
3. Berger R, Bernheim A, Brouet JC, et al. t(8;14) translocation in a Burkitt's type of lymphoblastic leukaemia (L3). Br J Haematol 1979;43:87-90. (Pubitemid 9251451)
4. Erikson J, Finan J, Nowell PC, et al. Translocation of immunoglobulin VH genes in Burkitt lymphoma. Proc Natl Acad Sci USA 1982;79:5611-5615.
5. Mussolin L, Basso K, Pillon M, et al. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by longdistance polymerase chain reaction for t(8;14)(q24;q32). Leukemia 2003;17:585-589.
6. Mussolin L, Pillon M, Conter V, et al. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood. J Clin Oncol 2007;25:5254-5261.
7. van Dongen JJ, Seriu T, Panzer-Grumayer ER, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998;352:1731-1738. (Pubitemid 28534955)
8. Szczepanski T, Willemse MJ, van Wering ER, et al. Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia 2001;15:1415-1423.
9. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
10. Pongers-Willemse MJ, Seriu T, Stolz F, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:110-118.
11. Langerak AW, Szczepanski T, van der Burg M, et al. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997;11:2192-2199.
12. Flohr T, Schrauder A, Cazzaniga G, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008;22:771-782.
13. Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 1998;12:2006-2014.
14. van der Velden VH, Cazzaniga G, Schrauder A, et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 2007;21:604-611.
15. Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995;155:190-202.
16. Volpe JM, Kepler TB. Large-scale analysis of human heavy chain V(D)J recombination patterns. Immunome Res 2008;4:3.
17. Yamada M, Wasserman R, Reichard BA, et al. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 1991;173:395-407.
18. Foster SJ, Brezinschek HP, Brezinschek RI, et al. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest 1997;99:1614-1627.
19. Klein R, Jaenichen R, Zachau HG. Expressed human immunoglobulin kappa genes and their hypermutation. Eur J Immunol 1993;23: 3248-3262.
20. Beishuizen A, de Bruijn MA, Pongers-Willemse MJ, et al. Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia 1997;11:2200-2207.
21. Ollila J, Vihinen M. B cells. Int J Biochem Cell Biol 2005;37:518-523.
22. Victor KD, Vu K, Feeney AJ. Limited junctional diversity in kappa light chains. Junctional sequences from CD43+B220+ early B cell progenitors resemble those from peripheral B cells. J Immunol 1994;152:3467-3475.
23. Cazzaniga G, Biondi A. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology. Haematologica 2005;90:382-390.